The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     
 


Published online June 24, 2009
The Journal of Immunology, 2009, doi:10.4049/jimmunol.0804354
Copyright © 2009 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jimmunol.0804354v1
183/2/1065    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Sharma, R.
Right arrow Articles by Ju, S.-T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sharma, R.
Right arrow Articles by Ju, S.-T.

IL-2 Regulates CD103 Expression on CD4+ T Cells in Scurfy Mice That Display Both CD103-Dependent and Independent Inflammation1

Rahul Sharma*, Sun-sang Joe Sung*, Christian E. Abaya*, Angela Chiao-Ying Ju*, Shu Man Fu*,{dagger},2 and Shyr-Te Ju*,{dagger},3,2

*Center for Immunity, Inflammation, and Regenerative Medicine, Department of Medicine, and {dagger}Department of Microbiology, University of Virginia, Charlottesville, VA 22908

Scurfy (Sf) mice lack CD4+Foxp3+ regulatory T cells and develop fatal multiorgan inflammation (MOI) mediated by CD4+ T cells. Introducing Il2–/– gene into Sf mice (Sf.Il2–/–) inhibited inflammation in skin and lung. As a major integrin receptor for the organs, we compared CD103 expression on the CD4+ T cells of B6, Il2–/–, Sf, and Sf.Il2–/– mice. CD103+CD4+ T cells, but not CD8+ T cells or CD11c+ dendritic cells, were significantly up-regulated only in Sf mice, indicating Il2–/– dominantly and specifically inhibited CD103 up-regulation in Sf CD4+ T cells. In addition, CD4+Foxp3+ regulatory T cell CD103 expression was not reduced in Il2–/– mice. Introducing CD103–/– into Sf mice inhibited inflammation in skin and lung as compared with age-matched Sf mice, but they died at ~7 wk old with inflammation developed in skin, lungs, and colon, demonstrating fatal MOI induced by CD103-independent mechanism. Transfer of Sf CD4+ T cells induced MOI more rapidly than CD103CD4+ T cells, indicating the presence of CD103-dependent mechanism for inflammation. In vitro stimulation with anti-CD3 plus anti-CD28 beads confirmed that CD103 induction in the CD4+Foxp3 T cells in Il2–/– and Sf.Il2–/– is defective and cannot be restored by rIL-2 or rIL-15. The data indicate that IL-2 is required for optimal CD103 induction on CD4+ T cells in Sf mice and this effect contributes to inflammation in an organ-specific manner. IL-2 also has additional roles because the protection of skin and lung inflammation in Sf.Il2–/–, but not Sf.CD103–/– mice is lifelong and Sf.Il2–/– mice have longer lifespan than Sf.CD103–/– mice.

3 Address correspondence and reprint requests to Dr. Shyr-Te Ju, Room 5777, 5th Floor, Old Medical School Building, Hospital Drive, University of Virginia, Charlottesville, VA 22908-0412. E-mail address: sj8r{at}virginia.edu

1 This work was supported by National Institutes of Health Grants DE-017579 and AR-051203 (to S.-T.J.), AR-047988 and AR-049449 (to S.M.F.), and AI-079906 (to S.-s.J.S.), and a grand-in-aid from the Beirne B. Carter Center of Immunology (to R.S.).

2 S.M.F. and S.-T.J., co-senior authors, contributed equally to this study.




This article has been cited by other articles:


Home page
J. Immunol.Home page
R. Sharma, U. S. Deshmukh, L. Zheng, S. M. Fu, and S.-T. Ju
X-linked Foxp3 (Scurfy) Mutation Dominantly Inhibits Submandibular Gland Development and Inflammation Respectively through Adaptive and Innate Immune Mechanisms
J. Immunol., September 1, 2009; 183(5): 3212 - 3218.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.